The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
Open accessAbstract
Despite recognizing the devastating consequences of metastasis, we are not yet able to effectively treat cancer that has spread to vital organs. The inherent complexity of genomic alterations in late-stage cancers, coupled with numerous heterotypic interactions that occur between tumour and stromal cells, represent fundamental challenges in our quest to understand and control metastatic disease. The incorporation of genomic and other systems level approaches, as well as technological breakthroughs in imaging and animal modelling, have galvanized the effort to overcome gaps in our understanding of metastasis. Future research carries with it the potential to translate the wealth of new knowledge and conceptual advances into effective targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–262 of 262
Arozarena, I., Sanchez-Laorden, B., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Viros, A., Sahai, E., & Marais, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.029 · Cited by 212
A Mouse Model of Human Breast Cancer Metastasis to Human Bone
Kuperwasser, C., Dessain, S., Bierbaum, B. E., Garnet, D., Sperandio, K., Gauvin, G. P., Naber, S. P., Weinberg, R. A., & Rosenblatt, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1408 · Cited by 212
Seike, T., Fujita, K., Yamakawa, Y., Kido, M. A., Takiguchi, S., Teramoto, N., Iguchi, H., & Noda, M. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9354-8 · Cited by 211
Cell tracking using a photoconvertible fluorescent protein
Hatta, K., Tsujii, H., & Omura, T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.96 · Cited by 210
Dai, J., Keller, J., Zhang, J., Lu, Y., Yao, Z., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1891 · Cited by 208
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., Que, I., Schwaninger, R., Rentsch, C., ten Dijke, P., Cleton-Jansen, A.-M., Driouch, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2490 · Cited by 204
A human MAP kinase interactome
Bandyopadhyay, S., Chiang, C.-Y., Srivastava, J., Gersten, M., White, S., Bell, R., Kurschner, C., Martin, C. H., Smoot, M., Sahasrabudhe, S., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1506 · Cited by 202
Buijs, J. T., Rentsch, C. A., van der Horst, G., van Overveld, P. G. M., Wetterwald, A., Schwaninger, R., Henriquez, N. V., ten Dijke, P., Borovecki, F., Markwalder, R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070168 · Cited by 200
Pratap, J., Wixted, J. J., Gaur, T., Zaidi, S. K., Dobson, J., Gokul, K. D., Hussain, S., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1078 · Cited by 191
Methodological and practical challenges for personalized cancer therapies
Wistuba, I. I., Gelovani, J. G., Jacoby, J. J., Davis, S. E., & Herbst, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.2 · Cited by 189
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
Park, Y.-G., Zhao, X., Lesueur, F., Lowy, D. R., Lancaster, M., Pharoah, P., Qian, X., & Hunter, K. W. (2005) · Nature Genetics · doi:10.1038/ng1635 · Cited by 180
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia
Williams, R. T., den Besten, W., & Sherr, C. J. (2007) · Genes & Development · doi:10.1101/gad.1588607 · Cited by 180
Ara, T., Song, L., Shimada, H., Keshelava, N., Russell, H. V., Metelitsa, L. S., Groshen, S. G., Seeger, R. C., & DeClerck, Y. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0613 · Cited by 175
KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer
Gumireddy, K., Li, A., Gimotty, P. A., Klein-Szanto, A. J., Showe, L. C., Katsaros, D., Coukos, G., Zhang, L., & Huang, Q. (2009) · Nature Cell Biology · doi:10.1038/ncb1974 · Cited by 174
Shekhar, M. P., Pauley, R., & Heppner, G. (2003) · Breast Cancer Research · doi:10.1186/bcr580 · Cited by 170
Learning therapeutic lessons from metastasis suppressor proteins
Smith, S. C., & Theodorescu, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2594 · Cited by 170
Xue, H., Lü, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., & Lai, M. (2010) · Journal of Proteome Research · doi:10.1021/pr9008817 · Cited by 169
Dai, J., Hall, C. L., Escara-Wilke, J. F., Mizokami, A., Keller, J. M., & Keller, E. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6541 · Cited by 169
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions
Feeley, B. T., Krenek, L., Liu, N., Hsu, W. K., Gamradt, S. C., Schwarz, E. M., Huard, J., & Lieberman, J. R. (2005) · Bone · doi:10.1016/j.bone.2005.07.015 · Cited by 165
Farina, K. L., Wyckoff, J. B., Rivera, J., Lee, H., Segall, J. E., Condeelis, J. S., & Jones, J. G. (1998) · PubMed · Cited by 162
Overexpression of Collagenase 1 (MMP-1) Is Mediated by the ERK Pathway in Invasive Melanoma Cells
Huntington, J. T., Shields, J. M., Der, C. J., Wyatt, C. A., Benbow, U., Slingluff, C. L., & Brinckerhoff, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405102200 · Cited by 161
Miles, D., Harbeck, N., Escudier, B., Hurwitz, H., Saltz, L., Van Cutsem, E., Cassidy, J., Mueller, B., & Sirzén, F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2794 · Cited by 158
Sessa, C., Guibal, A., Conte, G. D., & Rüegg, C. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1150 · Cited by 157
Mechanisms of Disease: angiogenesis and the management of breast cancer
Banerjee, S. N., Dowsett, M., Ashworth, A., & Martin, L. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0905 · Cited by 156
CanPredict: a computational tool for predicting cancer-associated missense mutations
Kaminker, J. S., Zhang, Y., Watanabe, C., & Zhang, Z. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm405 · Cited by 153
Hynes, R. O. (2003) · Cell · doi:10.1016/s0092-8674(03)00468-9 · Cited by 152
Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
Old, W. M., Shabb, J. B., Houel, S., Wang, H., Couts, K. L., Yen, C.-Y., Litman, E. S., Croy, C. H., Meyer-Arendt, K., Miranda, J. G., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.007 · Cited by 137
Sterling, J. A. R., Oyajobi, B. O., Grubbs, B. G., Padalecki, S. S., Munoz, S. A., Gupta, A., Story, B. M., Zhao, M., & Mundy, G. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0452 · Cited by 135
Bu, G., Lü, W., Liu, C., Selander, K. S., Yoneda, T., Hall, C. L., Keller, E. T., & Li, Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.23625 · Cited by 132
Leth‐Larsen, R., Lund, R. R., Hansen, H. V., Lænkholm, A., Tarin, D., Jensen, O. N., & Ditzel, H. J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800061-mcp200 · Cited by 129
Hunter, K. W., Broman, K. W., Voyer, T. L., Lukes, L., Cozma, D., Debies, M. T., Rouse, J., & Welch, D. R. (2001) · PubMed · Cited by 127
Therapeutic targeting of the prostate cancer microenvironment
Κάρλου, Μ., Tzelepi, V., & Efstathiou, E. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.134 · Cited by 123
Genetic background is an important determinant of metastatic potential
Hunter, K. W., Welch, D. R., & Liu, E. T. (2003) · Nature Genetics · doi:10.1038/ng0503-23b · Cited by 117
The HSC niche concept has turned 31: Has our knowledge matured?
Lymperi, S., Ferraro, F., & Scadden, D. T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05223.x · Cited by 113
Yonou, H., Yokose, T., Kamijo, T., Kanomata, N., Hasebe, T., Nagai, K., Hatano, T., Ogawa, Y., & Ochiai, A. (2001) · PubMed · Cited by 108
TGF-β and BMP7 interactions in tumour progression and bone metastasis
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., ten Dijke, P., & van der Pluijm, G. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9118-2 · Cited by 107
Luque-Garcia, J. L., Martinez-Torrecuadrada, J. L., Epifano, C., Cañamero, M., Babel, I., & Casal, J. I. (2010) · PROTEOMICS · doi:10.1002/pmic.200900441 · Cited by 105
Klein, R. M., & Aplin, A. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3201 · Cited by 102
Scherbarth, S., & Orr, F. W. (1997) · PubMed · Cited by 94
Yao, H., Zhang, Z., Xiao, Z., Chen, Y., li, C., Zhang, P., Li, M., Liu, Y., Guan, Y., Yu, Y., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.024 · Cited by 81
In vivo selection for metastasis promoting genes in the mouse
Gumireddy, K., Sun, F., Klein–Szanto, A. J., Gibbins, J. M., Gimotty, P. A., Saunders, A. J., Schultz, P. G., & Huang, Q. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701145104 · Cited by 80
Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis
Lipton, A., & Goessl, C. D. (2010) · Bone · doi:10.1016/j.bone.2010.10.161 · Cited by 78
Metastasis suppressors and the tumor microenvironment
Cook, L. M., Hurst, D. R., & Welch, D. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.005 · Cited by 67
Epigenetics: Unravelling the cancer code
Brower, V. (2011) · Nature · doi:10.1038/471s12a · Cited by 66
Massoud, T. F., Paulmurugan, R., & Gambhir, S. S. (2010) · Nature Medicine · doi:10.1038/nm.2185 · Cited by 64
Dendra2 Photoswitching through the Mammary Imaging Window
Gligorijevic, B., Kedrin, D., Segall, J. E., Condeelis, J. S., & van Rheenen, J. (2009) · Journal of Visualized Experiments · doi:10.3791/1278 · Cited by 63
Induction of Epigenetic Alterations by Chronic Inflammation and Its Significance on Carcinogenesis
Niwa, T., & Ushijima, T. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00002-x · Cited by 62
Ewald, A. J., Werb, Z., & Egeblad, M. (2011) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top97 · Cited by 56
Emmenegger, U., & Kerbel, R. S. (2010) · Nature · doi:10.1038/468637a · Cited by 54
Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization
Erez, N., & Coussens, L. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26032 · Cited by 50
Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation
Zunich, S. M., Douglas, T., Valdovinos, M., Chang, T., BUSHMAN, W. A., Walterhouse, D. O., Iannaccone, P. M., & Lamm, M. L. G. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-12 · Cited by 45
Francia, G., Man, S., Lee, C.-J., Lee, C. R., Xu, P., Mossoba, M. E., Emmenegger, U., Medin, J. A., & Kerbel, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0931 · Cited by 44
Dysregulation of developmental pathways in bone metastasis
Sethi, N. S., & Kang, Y. (2010) · Bone · doi:10.1016/j.bone.2010.07.005 · Cited by 44
Self-citationDrug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies
Reinacher‐Schick, A., Pohl, M., & Schmiegel, W. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1097 · Cited by 41
Kan, Z., & Liu, T.-J. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026478105365 · Cited by 33
Molecular imaging of tumor invasion and metastases: the role of MRI
McCann, T. E., Kosaka, N., Türkbey, B., Mitsunaga, M., Choyke, P. L., & Kobayashi, H. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1590 · Cited by 29
Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?
Cabodi, S., & Taverna, D. (2010) · Breast Cancer Research · doi:10.1186/bcr2563 · Cited by 29
Computational Micromodel for Epigenetic Mechanisms
Raghavan, K., Ruskin, H. J., Perrin, D., Goasmat, F., & Burns, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014031 · Cited by 24
Cross-species comparisons of cancer signaling
Graeber, T. G., & Sawyers, C. L. (2004) · Nature Genetics · doi:10.1038/ng0105-7 · Cited by 21
BRAF Inhibitor Unveils Its Potential against Advanced Melanoma
Vultur, A., Villanueva, J., & Herlyn, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.001 · Cited by 21
Inhibition of Mutated BRAF in Melanoma
Kim, T., Kim, J., & Lee, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1010755 · Cited by 18
The Yin and Yang of Treating BRCA-Deficient Tumors
Martin, R. W., Connell, P. P., & Bishop, D. K. (2008) · Cell · doi:10.1016/j.cell.2008.03.006 · Cited by 9
Cited by
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
Circulating tumor cells: biology and clinical significance
Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., Zhu, F., Zhou, D., Zheng, S., Chen, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00817-8 · Cited by 993
Metadata
- Authors
- Sethi, N., & Kang, Y.
- Venue
- Nature Reviews Cancer
- Published
- 2011-09-23
- Volume
- 11
- Issue
- 10
- Pages
- 735-748
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1976992968
- Cited by
- 397
- References
- 262
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.